Document is current
Any future updates will be listed below
-
Authors
Diskin, Brian
Adam, Salma
Cassini, Marcelo F.
Sanchez, Gustavo
Liria, Miguel
Aykut, Berk
Buttar, Chandan
Li, Eric
Sundberg, Belen
Salas, Ruben D.
Chen, Ruonan
Wang, Junjie
Kim, Mirhee
Farooq, Mohammad Saad
Nguy, Susanna
Fedele, Carmine
Tang, Kwan Ho
Chen, Ting https://orcid.org/0000-0003-1725-7956
Wang, Wei
Hundeyin, Mautin
Rossi, Juan A. Kochen
Kurz, Emma
Haq, Muhammad Israr Ul
Karlen, Jason
Kruger, Emma
Sekendiz, Zennur
Wu, Dongling
Shadaloey, Sorin A. A.
Baptiste, Gillian
Werba, Gregor
Selvaraj, Shanmugapriya
Loomis, Cynthia
Wong, Kwok-Kin
Leinwand, Joshua
Miller, George https://orcid.org/0000-0001-8482-4100
- License Information
-
More Information
Article History
Received: 16 January 2019
Accepted: 24 January 2020
First Online: 9 March 2020
Competing interests
: G.M. has research agreements with GSK, Pfizer and Puretech Health. K.K.W. is a founder and equity holder of G1 Therapeutics and has sponsored research agreements with MedImmune, Takeda, TargImmune, Bristol-Myers Squibb, Mirati, Merus and Alkermes, and has consulting and sponsored research agreements with AstraZeneca, Janssen, Pfizer, Novartis, Merck, Ono and Array. The remaining authors declare no competing interests.
